US EditionMedicare Spends Billions on Oncology Drugs Offering Little Added Benefit
Summary by MedPage Today
2 Articles
2 Articles
All
Left
Center
1
Right
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsMedicare Spends Billions on Oncology Drugs Offering Little Added Benefit
(MedPage Today) -- In an analysis of Medicare's top-selling brand-name oncology drugs, researchers found that while the vast majority provided high added therapeutic benefit, 10 were classified as providing low or no added benefit. In 2022, Medicare...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
